BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 23842643)

  • 1. Therapeutics: Embracing instability.
    McCarthy N
    Nat Rev Cancer; 2013 Aug; 13(8):521. PubMed ID: 23842643
    [No Abstract]   [Full Text] [Related]  

  • 2. Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma.
    Brockmann M; Poon E; Berry T; Carstensen A; Deubzer HE; Rycak L; Jamin Y; Thway K; Robinson SP; Roels F; Witt O; Fischer M; Chesler L; Eilers M
    Cancer Cell; 2013 Jul; 24(1):75-89. PubMed ID: 23792191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notching up MYC gives a LIC.
    Levens D; Aplan PD
    Cell Stem Cell; 2013 Jul; 13(1):8-9. PubMed ID: 23827704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival.
    Xiao D; Yue M; Su H; Ren P; Jiang J; Li F; Hu Y; Du H; Liu H; Qing G
    Mol Cell; 2016 Nov; 64(3):493-506. PubMed ID: 27773673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability.
    King B; Trimarchi T; Reavie L; Xu L; Mullenders J; Ntziachristos P; Aranda-Orgilles B; Perez-Garcia A; Shi J; Vakoc C; Sandy P; Shen SS; Ferrando A; Aifantis I
    Cell; 2013 Jun; 153(7):1552-66. PubMed ID: 23791182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-ALL: ALL a matter of Translation?
    Girardi T; De Keersmaecker K
    Haematologica; 2015 Mar; 100(3):293-5. PubMed ID: 25740104
    [No Abstract]   [Full Text] [Related]  

  • 7. TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation.
    Li K; Wang F; Yang ZN; Zhang TT; Yuan YF; Zhao CX; Yeerjiang Z; Cui B; Hua F; Lv XX; Zhang XW; Yu JJ; Liu SS; Yu JM; Shang S; Xiao Y; Hu ZW
    Nat Commun; 2020 Dec; 11(1):6316. PubMed ID: 33298911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.
    Yada M; Hatakeyama S; Kamura T; Nishiyama M; Tsunematsu R; Imaki H; Ishida N; Okumura F; Nakayama K; Nakayama KI
    EMBO J; 2004 May; 23(10):2116-25. PubMed ID: 15103331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation.
    Xi Z; Yao M; Li Y; Xie C; Holst J; Liu T; Cai S; Lao Y; Tan H; Xu HX; Dong Q
    Cell Death Dis; 2016 Jun; 7(6):e2252. PubMed ID: 27253416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Function and mechanism of tumor suppressor gene FBW7 in tumorigenesis].
    Huang HJ; Zheng F; Xu FP; Liu YH; Zhuang HG
    Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):214-6. PubMed ID: 23769449
    [No Abstract]   [Full Text] [Related]  

  • 11. Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma.
    Otto T; Horn S; Brockmann M; Eilers U; Schüttrumpf L; Popov N; Kenney AM; Schulte JH; Beijersbergen R; Christiansen H; Berwanger B; Eilers M
    Cancer Cell; 2009 Jan; 15(1):67-78. PubMed ID: 19111882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia.
    Palomero T; Ferrando A
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3(Suppl 3):S205-10. PubMed ID: 19778842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cell cycle regulation by F-box protein Fbxw7].
    Tsunematsu R
    Fukuoka Igaku Zasshi; 2009 Apr; 100(4):87-94. PubMed ID: 19562935
    [No Abstract]   [Full Text] [Related]  

  • 14. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia.
    Thompson BJ; Buonamici S; Sulis ML; Palomero T; Vilimas T; Basso G; Ferrando A; Aifantis I
    J Exp Med; 2007 Aug; 204(8):1825-35. PubMed ID: 17646408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation.
    Welcker M; Orian A; Jin J; Grim JE; Harper JW; Eisenman RN; Clurman BE
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9085-90. PubMed ID: 15150404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel, potent and selective inhibitors of Polo-like kinase 1.
    Chen S; Bartkovitz D; Cai J; Chen Y; Chen Z; Chu XJ; Le K; Le NT; Luk KC; Mischke S; Naderi-Oboodi G; Boylan JF; Nevins T; Qing W; Chen Y; Wovkulich PM
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1247-50. PubMed ID: 22172702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation mechanism of Fbxw7-related signaling pathways (Review).
    Zhou Z; He C; Wang J
    Oncol Rep; 2015 Nov; 34(5):2215-24. PubMed ID: 26324296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size.
    Welcker M; Orian A; Grim JE; Eisenman RN; Clurman BE
    Curr Biol; 2004 Oct; 14(20):1852-7. PubMed ID: 15498494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fbw7 promotes ubiquitin-dependent degradation of c-Myb: involvement of GSK3-mediated phosphorylation of Thr-572 in mouse c-Myb.
    Kitagawa K; Hiramatsu Y; Uchida C; Isobe T; Hattori T; Oda T; Shibata K; Nakamura S; Kikuchi A; Kitagawa M
    Oncogene; 2009 Jun; 28(25):2393-405. PubMed ID: 19421138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase.
    Wei W; Jin J; Schlisio S; Harper JW; Kaelin WG
    Cancer Cell; 2005 Jul; 8(1):25-33. PubMed ID: 16023596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.